Bosutinib
In Stock•Starting at $9 for 1 mg•Purity ≥ 99%
| CAS No. | 380843-75-4 |
|---|---|
| MDL No. | MFCD07367846 |
| MF | C26H29Cl2N5O3 |
| MW | 530.40 |
| InChI Key | UBPYILGKFZZVDX-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $9 | In Stock | |
| 10 mg | 99% | $21 | In Stock | |
| 100 mg | 99% | $25 | In Stock | |
| 250 mg | 99% | $48 | In Stock | |
| 1 g | 99% | $68 | In Stock |
Product Information
Bosutinib is an aminoquinoline with the structure 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline, featuring cyano and methoxy groups at positions 3 and 6, respectively. It functions as an antineoplastic agent and tyrosine kinase inhibitor, and is classified as a nitrile, N-methylpiperazine, aromatic ether, tertiary amino compound, and dichlorobenzene.
| CAS No. | 380843-75-4 |
|---|---|
| Product Name | Bosutinib |
Biological Targets
ABL1·BCR·HCK·LYN·SRC
Associated Conditions
acute myeloid leukemia·cervical cancer·Cognitive impairment·myeloid leukemia·Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive·
* The information provided here is compiled from public sources and is for reference only.
